Hygeia Healthcare Holdings Acquires Chang An Hospital in Deal Valued at RMB 1.66 Billion
Hygeia Healthcare Holdings Co., Ltd, a Shanghai-based medical investment and healthcare group, has announced the...
Finance
Eisai and SEED Therapeutics Join Forces on Molecular Glue Degraders for Neurodegeneration and Cancer
Eisai Co., Ltd (TYO: 4523), a Japanese pharmaceutical company, and SEED Therapeutics Inc., a U.S....
Shanghai Aims to Become Capital Market Hub for High-Quality Science and Innovation Companies
The Shanghai municipal government has unveiled a comprehensive set of measures designed to enhance the...
Shenzhen-Based Synthetica Secures Initial Funding to Advance Oncolytic Bacteria Pipeline
Synthetica, a pioneering developer of live bacteria drugs based in Shenzhen, has announced the successful...
Suzhou Hanerxi Medical Secures Series B Funding to Build Asia’s Largest Pen Injector Facility
Suzhou Hanerxi Medical Device Development Co., Ltd, a specialist in pen syringe technology based in...
GSK Enters into Strategic Partnership with Flagship Pioneering to Develop Novel Medicines and Vaccines
UK pharmaceutical giant GlaxoSmithKline (GSK; NYSE: GSK, LON: GSK) has announced a new partnership with...
Livzon Pharmaceutical Group to Establish Joint Venture with PT Kalbe Farma in Indonesia
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced plans to form a joint venture...
LTZ Therapeutics Secures Over USD 20 Million in Series A Financing to Advance Immunotherapy Pipeline
LTZ Therapeutics Inc., a biotechnology company specializing in immunotherapy with operations in both the US...
Guangzhou Red Pine Medical Secures Series D Funding to Accelerate Global Expansion
Guangzhou Red Pine Medical Instrument Co., Ltd., a leading company in the disposable endoscope sector,...
Bristol-Myers Squibb Q2 2024 Sales Boosted by Growth Portfolio, Offset by R&D Impairment
Bristol-Myers Squibb (BMS; NYSE: BMY) has announced its financial results for the second quarter of...
Shanghai’s Spectrum Dynamics Medical Secures Major Financing for Molecular Imaging Innovations
Spectrum Dynamics Medical, a Shanghai-based specialist in medical molecular imaging, has reportedly secured hundreds of...
AstraZeneca’s Q2 2024 Results Highlight Strong Growth Across Therapies, Excluding Vaccines
AstraZeneca (NASDAQ: AZN), a UK-based biopharmaceutical company, has reported its financial results for the second...
RemeGen Scales Back Private Placement to Fund New Drug R&D
RemeGen (HKG: 9995), a biopharmaceutical company based in China, has revised its private placement plan,...
Shanghai Desano and Chongqing Kangfude Partner to Establish Peptide Drug Production Base in China
Shanghai Desano Biopharmaceutical Co., Ltd, a leading biopharmaceutical company based in China, has entered into...
Fosun Pharma and Kite Pharma Inject USD 28.5 Million into Joint Venture for CAR-T Therapy Development
Shanghai Fosun Pharmaceutical Group Co., Ltd (SHA: 600196; HKG: 2196) and Kite Pharma, a subsidiary...
MicroPort CardioFlow Secures Exclusive Distribution Rights for Evermend Occluders in China
MicroPort Scientific Corp (HKG: 0853), a leading medical device company based in China, has announced...
Rona Therapeutics Secures USD 35 Million in Series A+ Round to Advance Nucleic Acid Therapies
Rona Therapeutics, a Shanghai-based nucleic acid drug developer, has secured USD 35 million in a...
Beijing X-Magtech Secures Over RMB 100 Million in Series A+ Funding for Magnetic Field Measurement Tech
Beijing X-Magtech Technologies, a specialist in ultra-weak magnetic field measurement technology, has reportedly secured over...
Guotai Junan and Haitong Securities to Launch $10 Billion in Industry Funds in Shanghai
China’s prominent financial institutions, Guotai Junan Securities and Haitong Securities, have revealed plans to establish...
E-Health Now Secures USD 13.8 Million in Series C Financing to Expand AI Medical Services
E-Health Now, a China-based one-stop artificial intelligence (AI)-powered medical health service platform, has reportedly secured...